Search

everythinglearnresearchcommunity

for

Search:↓

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Early balding, especially frontal, increases prostate cancer risk; more research needed.

No definitive link between finasteride and male breast cancer, but further research is needed.

TURP is the best treatment for BPH, but some patients prefer medications like alpha-blockers and finasteride.

Finasteride reduces prostate cancer risk but may increase high-grade cancer chances.

Finasteride may help reduce inappropriate sexual behaviors in dementia patients with prostate issues.

Case-only trees and random forests improve predictions of treatment effects in clinical trials.

5α-reductase inhibitors help treat disorders caused by DHT and have potential for future therapies.

A new compound was effective for imaging prostate cancer in rats.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

Finasteride before TURP reduces blood loss and slightly improves early postoperative quality of life.

Both terazosin and baclofen effectively reduce pain in young men with chronic testicular pain, with no difference in their effectiveness.

Dutasteride is effective for treating prostate enlargement and reducing related surgery risk, but is not approved for preventing prostate cancer.

Baldness score can't be used to predict prostate size.

Testosterone creams and gels can be effective but have serious risks and should be used only with medical supervision.

Menopause is a clear hormonal transition in women, while men experience a gradual testosterone decline, with some needing lifestyle changes and targeted therapy.

Prostatitis is a common male condition with various causes and treatments, often involving antibiotics and lifestyle changes.

Alpha-blockers and 5-alpha reductase inhibitors are main treatments for BPH, with new support for phosphodiesterase-5 inhibitors and beta-3 agonists.

A young man with high-grade prostate cancer had successful surgery and good recovery, highlighting the need for awareness in younger men.

COVID-19 can cause different types of hair loss, with telogen effluvium being the most common.

5α-reductase inhibitors like Finasteride and Dutasteride may help manage prostate cancer by blocking testosterone conversion.

Finasteride can reduce prostate cancer risk but may delay diagnosis and cause sexual side effects.

Higher cholesterol levels increase aggressive prostate cancer risk.

Testosterone replacement therapy improves libido, mood, muscle strength, and bone density in men with Testosterone Deficiency Syndrome.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

Dr. Mario Lacouture recommends preventive and specific treatments for skin side effects caused by EGFR inhibitors to improve patients' quality of life.

Age, race, family history, and certain genetic factors increase prostate cancer risk.

The conclusion is that doctors should be careful when prescribing 5α-reductase inhibitors due to possible serious side effects, and they should discuss these risks with patients.

Higher BMI is linked to a lower risk of non-aggressive prostate cancer and a higher risk of aggressive prostate cancer.

Being obese and eating too many calories may increase the risk of kidney cancer, but physical activity doesn't seem to affect this risk.